AVITA Medical, Inc. (RCEL) Form 424B5 — Jun 5, 2026
AVITA Medical (RCEL) filed a prospectus supplement registering up to 650,000 shares of common stock issuable upon exercise of warrants held by Perceptive Credit Holdings V, LP. These warrants were issued as part of a $60 million credit facility entered into in January 2026, with an exercise price of $3.4019 per share. The filing discloses that the company has 30.8 million shares outstanding and a negative net tangible book value of $1.02 per share as of March 31, 2026. Full exercise of the warrants would yield approximately $2.2 million in proceeds, representing a modest dilution of roughly 2% to existing shareholders.
Key figures
- Total Debt
- 0
- Debt Amount
- 60000000
- Cash Position
- 0
- Gross Proceeds
- 2200000
- Offering Price
- 3.4019
- Shares Offered
- 650000
- Shares Outstanding
- 30776689
- Barda Agreement Value
- 25500000
- Net Proceeds From Debt
- 6000000
- Ttm Revenue Covenant FY 2026
- 73000000
- Ttm Revenue Covenant Q2 2026
- 69000000
- Additional Commitment Amount
- 10000000
- Dilution Per Share To Warrant Holder
- 4.32
Price after filing
Close on the filing date to close N calendar days later (from $4.36). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.